Page last updated: 2024-12-07

methyl 4-mercaptobutyrimidate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyl 4-mercaptobutyrimidate: used as a cross-linking agent to study ribosomal proteins, by making disulfide linkages; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123925
CHEBI ID195569
SCHEMBL ID56570
MeSH IDM0047767

Synonyms (10)

Synonym
methyl 4-sulfanylbutanimidate
64821-63-2
methyl 4-sulanylbutanimidate
CHEBI:195569
methyl 4-mercaptobutyrimidate
9zqt0d3dbv ,
butanimidic acid, 4-mercapto-, methyl ester
unii-9zqt0d3dbv
SCHEMBL56570
DTXSID30983418

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" We also observed that crosslinking formed within the collagen scaffolds with excess dosage of Sulfo-SMCC, which improved the biological performance of collagen scaffolds together with growth factors."( Improved performance of collagen scaffolds crosslinked by Traut's reagent and Sulfo-SMCC.
Cheng, X; Deng, F; He, Q; Hu, X; Li, X; Li, Y; Liu, Y, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
oxoacid derivative
organonitrogen compoundAny heteroorganic entity containing at least one carbon-nitrogen bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (83)

TimeframeStudies, This Drug (%)All Drugs %
pre-199039 (46.99)18.7374
1990's16 (19.28)18.2507
2000's16 (19.28)29.6817
2010's11 (13.25)24.3611
2020's1 (1.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.78 (24.57)
Research Supply Index4.52 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other91 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]